Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

被引：0
|
作者：
Alessandro Mantovani
Mario Luca Morieri
Luisa Palmisano
Maria Masulli
Efisio Cossu
Marco Giorgio Baroni
Katia Bonomo
Flavia Agata Cimini
Gisella Cavallo
Raffaella Buzzetti
Carmen Mignogna
Frida Leonetti
Simonetta Bacci
Roberto Trevisan
Riccardo Maria Pollis
Raffaella Aldigeri
Alessandra Dei Cas
Saula Vigili de Kreutzenberg
Giovanni Targher
机构：
[1] University of Verona,Section of Endocrinology, Diabetes and Metabolism, Department of Medicine
[2] University of Padua,Metabolic Diseases, Department of Medicine
[3] Federico II University,Department of Clinical Medicine and Surgery
[4] Policlinico Universitario of Cagliari,Diabetology Unit
[5] University of Aquila,Department of Clinical Medicine, Life, Health and Environmental Sciences
[6] IRCCS Neuromed,Neuroendocrinology and Metabolic Diseases
[7] San Luigi Gonzaga University Hospital,Diabetes and Metabolic Diseases Unit
[8] Sapienza University,Department of Experimental Medicine
[9] Sapienza University,Department of Medical
[10] IRCCS Casa Sollievo della Sofferenza Hospital,Surgical Sciences and Biotechnologies
[11] University of Milan Bicocca,Section of Endocrinology, Department of Medicine
[12] Azienda Ospedaliero-Universitaria,Department of Medicine and Surgery
[13] University of Parma,Division of Nutritional and Metabolic Sciences
[14] IRCCS Sacro Cuore Don Calabria Hospital,Department of Medicine and Surgery
[15] University and Azienda Ospedaliera Universitaria Integrata,Section of Endocrinology, Diabetes and Metabolism, Department of Medicine
来源：
Cardiovascular Diabetology | / 22卷
关键词：
NAFLD; Non-alcoholic fatty liver disease; T1DM; Type 1 diabetes; CVD; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
    Mantovani, Alessandro
    Morieri, Mario Luca
    Palmisano, Luisa
    Masulli, Maria
    Cossu, Efisio
    Baroni, Marco Giorgio
    Bonomo, Katia
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Aldigeri, Raffaella
    Cas, Alessandra Dei
    de Kreutzenberg, Saula Vigili
    Targher, Giovanni
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] HEPATIC STEATOSIS IS ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENT RATE AMONG PEOPLE AT LOW 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
    Karady, Julia
    Mayrhofer, Thomas
    Foldyna, Borek
    Lu, Michael T.
    Mehyerson, Nandini
    Hoffmann, Udo
    Pagidipati, Neha
    Shah, Svati
    Douglas, Pamela S.
    Ferencik, Maros
    Corey, Kathleen E.
    HEPATOLOGY, 2023, 78 : S140 - S141
  • [3] Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus
    Wang, Wei
    Lv, Feng Yan
    Tu, Mei
    Guo, Xiu Li
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [4] MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
    Mantovani, Alessandro
    Morieri, Mario Luca
    Aldigeri, Raffaella
    Palmisano, Luisa
    Masulli, Maria
    Bonomo, Katia
    Baroni, Marco Giorgio
    Cossu, Efisio
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Dei Cas, Alessandra
    Kreutzenberg, Saula Vigili de
    Targher, Giovanni
    DIABETES & METABOLISM, 2024, 50 (01)
  • [5] Severity of hepatic steatosis is associated with atherosclerotic cardiovascular disease and type 2 diabetes mellitus
    Ayonrinde, Oyekoya
    Adams, Leon A.
    Mori, Trevor
    Melton, Phillip
    Olynyk, John
    Zelesco, Marilyn
    Mould, Andrea
    Fiori, James
    Beilin, Lawrence
    Dwivedi, Girish
    Sanfilippo, Frank
    Welman, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 130 - 130
  • [6] Blood glucose fluctuation is associated with the 10-year risk for cardiovascular disease among individuals with type 2 diabetes mellitus
    Tang Xixiang
    Peng Long
    Chen Yanming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C113 - C113
  • [7] Effect of Sarcopenia on 10-Year Risk of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Xia, Long-Fei
    Li, Jing-Bo
    Tian, Guo-Sheng
    Jiang, Wei -Ran
    Li, Yao-Shuang
    Lin, Chen-Ying
    Qiu, Hui-Na
    Wu, Fan
    Wang, Jun-Jia
    Li, Chun -Jun
    Lin, Jing-Na
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1621 - 1634
  • [8] Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes
    Claro Brandner, M.
    Milad, C.
    Ayala, D.
    Figueredo, C.
    Vinals, C.
    Conget, I.
    Seres-Noriega, T.
    Perea, V.
    Mesa, A.
    Boswell, L.
    Blanco Carrasco, A.
    Esmatjes, E.
    Gimenez, M.
    Amor Fernandez, A.
    DIABETOLOGIA, 2024, 67 : S471 - S471
  • [9] 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
    Gyldenkerne, Christine
    Mortensen, Martin Bodtker
    Kahlert, Johnny
    Thrane, Pernille Gro
    Olesen, Kevin Kris Warnakula
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    Maeng, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (16) : 1583 - 1594
  • [10] Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis
    Petit, J. -M.
    Pedro, L.
    Guiu, B.
    Duvillard, L.
    Bouillet, B.
    Jooste, V.
    Habchi, M.
    Crevisy, E.
    Fourmont, C.
    Buffier, P.
    Hillon, P.
    Cercueil, J. -P.
    Verges, B.
    DIABETIC MEDICINE, 2015, 32 (12) : 1648 - 1651
12345